Status:
COMPLETED
Hemostatic Profiles of Endocrine Therapies for Breast Cancer
Lead Sponsor:
University Hospital, Geneva
Conditions:
Breast Neoplasms
Venous Thromboembolism
Eligibility:
FEMALE
18+ years
Brief Summary
The aim of this prospective cohort study is to evaluate the modifications of the biological hemostatic profile associated with the use of endocrine therapy in women with breast cancer (tamoxifen or ar...
Detailed Description
In this cohort study, women with breast cancer and an indication for endocrine therapy will be prospectively enrolled. At the 1st visit (before the start of endocrine therapy (tamoxifen or aromatase i...
Eligibility Criteria
Inclusion
- adult women with a diagnosis of non-metastatic breast cancer and an indication for adjuvant endocrine therapy
Exclusion
- lack of consent
- planned chemotherapy
- personal history of venous thromboembolism
- ongoing anticoagulant treatment
Key Trial Info
Start Date :
April 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 28 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03381963
Start Date
April 1 2017
End Date
February 28 2020
Last Update
April 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Geneva University Hospitals
Geneva, Switzerland